Full Content is available to subscribers

Subscribe/Learn More  >
Proceedings Article

Optogenetic stimulation of cholinergic projection neurons as an alternative for deep brain stimulation for Alzheimer’s treatment

[+] Author Affiliations
James Mancuso, Yuanxin Chen, Zhen Zhao, Xuping Li, Zhong Xue, Stephen T. C. Wong

Weill Cornell Medical College (United States)

Proc. SPIE 8565, Photonic Therapeutics and Diagnostics IX, 85655M (March 8, 2013); doi:10.1117/12.2004379
Text Size: A A A
From Conference Volume 8565

  • Photonic Therapeutics and Diagnostics IX
  • Nikiforos Kollias; Bernard Choi; Haishan Zeng; Hyun Wook Kang; Bodo E. Knudsen; Brian J. Wong; Justus F. Ilgner; Melissa J. Suter; Stephen Lam; Matthew Brenner; Kenton W. Gregory; Guillermo J. Tearney; Laura Marcu; Henry Hirschberg; Steen J. Madsen; Anita Mahadevan-Jansen; E. Duco Jansen; Andreas Mandelis; Michael D. Morris
  • San Francisco, California, USA | February 02, 2013

abstract

Deep brain stimulation (DBS) of the cholinergic nuclei has emerged as a powerful potential treatment for neurodegenerative disease and is currently in a clinical trial for Alzheimer’s therapy. While effective in treatment for a number of conditions from depression to epilepsy, DBS remains somewhat unpredictable due to the heterogeneity of the projection neurons that are activated, including glutamatergic, GABAergic, and cholinergic neurons, leading to unacceptable side effects ranging from apathy to depression or even suicidal behavior. It would be highly advantageous to confine stimulation to specific populations of neurons, particularly in brain diseases involving complex network interactions such as Alzheimer’s. Optogenetics, now firmly established as an effective approach to render genetically-defined populations of cells sensitive to light activation including mice expressing Channelrhodopsin-2 specifically in cholinergic neurons, provides just this opportunity. Here we characterize the light activation properties and cell density of cholinergic neurons in healthy mice and mouse models of Alzheimer’s disease in order to evaluate the feasibility of using optogenetic modulation of cholinergic synaptic activity to slow or reverse neurodegeneration. This paper is one of the very first reports to suggest that, despite the anatomical depth of their cell bodies, cholinergic projection neurons provide a better target for systems level optogenetic modulation than cholinergic interneurons found in various brain regions including striatum and the cerebral cortex. Additionally, basal forebrain channelrhodopsin-expressing cholinergic neurons are shown to exhibit normal distribution at 60 days and normal light activation at 40 days, the latest timepoints observed. The data collected form the basis of ongoing computational modeling of light stimulation of entire populations of cholinergic neurons. © (2013) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Citation

James Mancuso ; Yuanxin Chen ; Zhen Zhao ; Xuping Li ; Zhong Xue, et al.
" Optogenetic stimulation of cholinergic projection neurons as an alternative for deep brain stimulation for Alzheimer’s treatment ", Proc. SPIE 8565, Photonic Therapeutics and Diagnostics IX, 85655M (March 8, 2013); doi:10.1117/12.2004379; http://dx.doi.org/10.1117/12.2004379


Access This Proceeding
Sign in or Create a personal account to Buy this proceeding ($15 for members, $18 for non-members).

Figures

Tables

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Book Chapters

Topic Collections

Advertisement


  • Don't have an account?
  • Subscribe to the SPIE Digital Library
  • Create a FREE account to sign up for Digital Library content alerts and gain access to institutional subscriptions remotely.
Access This Proceeding
Sign in or Create a personal account to Buy this proceeding ($15 for members, $18 for non-members).
Access This Proceeding
Sign in or Create a personal account to Buy this article ($15 for members, $18 for non-members).
Access This Chapter

Access to SPIE eBooks is limited to subscribing institutions and is not available as part of a personal subscription. Print or electronic versions of individual SPIE books may be purchased via SPIE.org.